Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04574830 · ClinicalTrials.gov registry record
Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
A clinical trial, sponsored by Ultragenyx Pharmaceutical.
- Completed
- Registry status
- 18
- Enrollment target
NCT04574830 is a clinical trial that has completed, run by Ultragenyx Pharmaceutical. The registered enrollment target is 18 participants.
The verdict
NCT04574830 has completed, sponsored by Ultragenyx Pharmaceutical.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate potential biomarkers of GSD III.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-11-23 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04574830
The ClinicalTrials.gov registry entry for NCT04574830 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ultragenyx Pharmaceutical, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT04574830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04574830 about?
NCT04574830 is a clinical study titled "Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)". The primary objective of this study is to evaluate potential biomarkers of GSD III.
What is the current status of trial NCT04574830?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2020-11-23. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04574830?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT04574830?
This trial is sponsored by Ultragenyx Pharmaceutical, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.